Clodoveo Ferri

Q: What Schools Are Affiliated With Clodoveo Ferri

Clodoveo Ferri is affiliated with the following schools: Consorzio ICoN, University of Modena and Reggio Emilia

Clodoveo Ferri's AcademicInfluence.com Rankings

Clodoveo Ferri

Criminal Justice

#195

World Rank

#221

Historical Rank

Criminology

#110

World Rank

#125

Historical Rank

criminal-justice Degrees

Download Badge

Criminal Justice

Why Is Clodoveo Ferri Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Clodoveo Ferri is an Italian researcher of clinical rheumatology, immunology and internal medicine. Since January 2003, Clodoveo Ferri has been a professor of rheumatology, Chief of the Chair of Rheumatology and director of the Postgraduate School of Rheumatology at the University of Modena and Reggio Emilia in Modena, Italy. A native of Cropani, a small town in Calabria, Italy, Clodoveo Ferri graduated cum laude from the University of Pisa and later specialized in internal medicine and rheumatology.

(See a Problem?)

Clodoveo Ferri's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients (2002) (756)
Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. (2004) (482)
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. (2014) (438)
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. (2012) (346)
European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes (2001) (320)
Hepatitis C virus infection in patients with non‐Hodgkin's lymphoma (1994) (293)
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. (2010) (290)
Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. (1993) (286)
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. (2007) (256)
Thyroid disorders in chronic hepatitis C. (2004) (240)
Prevalence of bcl-2 Rearrangement in Patients with Hepatitis C VirusRelated Mixed Cryoglobulinemia with or without B-Cell Lymphomas (2002) (211)
Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. (1991) (195)
Infection of Peripheral Blood Mononuclear Cells by Hepatitis C Virus in Mixed Cryoglobulinemia (1993) (195)
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. (2011) (190)
Cryoglobulinemic vasculitis (2006) (184)
Hepatitis C Virus Genotype Analysis in Patients with Type II Mixed Cryoglobulinemia (1996) (182)
Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database. (2006) (181)
Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. (2005) (178)
Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. (2009) (174)
T(14;18) translocation in chronic hepatitis C virus infection (2000) (171)
Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. (2011) (165)
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. (2012) (155)
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. (2007) (147)
Thyroid disorders in chronic hepatitis C virus infection. (2006) (147)
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature. (2015) (139)
Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. (1993) (136)
Preliminary classification criteria for the cryoglobulinaemic vasculitis (2011) (134)
Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer. (2015) (132)
Hepatitis C virus infection: evidence for an association with type 2 diabetes. (2005) (129)
Hepatitis C virus-related lymphoproliferative disorders: an overview. (2007) (127)
Lung involvement in essential mixed cryoglobulinemia. (1979) (120)
HCV-related autoimmune and neoplastic disorders: the HCV syndrome. (2007) (120)
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study (2016) (119)
Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study (2016) (119)
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. (2008) (118)
European multicentre study to define disease activity criteria for systemic sclerosis.* I. Clinical and epidemiological features of 290 patients from 19 centres (2001) (114)
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study (2011) (113)
Endocrine manifestations of hepatitis C virus infection (2009) (112)
HCV infection: pathogenesis, clinical manifestations and therapy. (2008) (112)
Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. (1992) (108)
Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis. (2007) (107)
Association between hepatitis C virus and mixed cryoglobulinemia (1991) (105)
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study. (2008) (103)
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. (2014) (101)
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series (2020) (100)
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement. (2016) (98)
Cytokines and HCV-Related Disorders (2012) (98)
Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. (2008) (97)
Heart involvement and systemic sclerosis (2005) (96)
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. (2017) (96)
Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin’s lymphoma: evidence for a pathogenetic role (1997) (95)
Longterm Retention of Tumor Necrosis Factor-α Inhibitor Therapy in a Large Italian Cohort of Patients with Rheumatoid Arthritis from the GISEA Registry: An Appraisal of Predictors (2012) (91)
Brief report: successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: an Italian multicenter study. (2012) (89)
Autonomic dysfunction in systemic sclerosis: time and frequency domain 24 hour heart rate variability analysis. (1997) (89)
Mixed cryoglobulinemia (2008) (88)
Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection (2015) (88)
Noninvasive evaluation of cardiac dysrhythmias, and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. (1985) (88)
Relation between infection and autoimmunity in mixed cryoglobulinemia. (2000) (88)
B-cells and mixed cryoglobulinemia. (2007) (86)
Thyroid cancer in HCV-related chronic hepatitis patients: a case-control study. (2007) (85)
Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma (2004) (84)
Cutaneous and serologic subsets of systemic sclerosis. (1991) (84)
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients (2016) (84)
Cryoglobulinaemia (2018) (84)
Hepatitis C virus infection in non‐Hodgkin's B‐cell lymphoma complicating mixed cryoglobulinaemia (1994) (84)
Thyroid cancer in patients with hepatitis C infection. (1999) (83)
Type 2 diabetes in hepatitis C-related mixed cryoglobulinaemia patients. (2003) (83)
Can type C hepatitis infection be complicated by malignant lymphoma? (1995) (82)
Hepatitis C virus infection and chronic kidney disease: Time for reappraisal. (2016) (82)
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature. (2014) (80)
High Values of CXCL10 Serum Levels in Mixed Cryoglobulinemia Associated With Hepatitis C Infection (2008) (80)
Hepatitis C virus‐related autoimmunity in patients with porphyria cutanea tarda (1993) (80)
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis. (2008) (80)
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. (2004) (79)
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. (2017) (77)
Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. (1997) (77)
Parvovirus B19 infection of bone marrow in systemic sclerosis patients. (1999) (76)
Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange. (1986) (75)
Thyroid cancer in HCV-related mixed cryoglobulinemia patients. (2002) (71)
Viruses and cancers: possible role of hepatitis C virus (1997) (69)
Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis. (2008) (69)
Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders (1998) (69)
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. (2016) (67)
RET TKI: Potential Role in Thyroid Cancers (2012) (66)
Validation of the classification criteria for cryoglobulinaemic vasculitis. (2014) (66)
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature. (2013) (65)
Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection. (1996) (64)
Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. (1989) (64)
Nailfold capillaroscopic changes in dermatomyositis and polymyositis (2015) (61)
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects (2006) (60)
Erectile dysfunction and hepatitis C virus infection. (2002) (59)
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. (2008) (59)
HCV-related autoimmune disorders in HCV chronic infection. (2013) (58)
Mixed cryoglobulinemia as a possible preneoplastic disorder. (1995) (58)
Non-Hodgkin's lymphoma: possible role of hepatitis C virus. (1994) (57)
The dermatopathologic manifestations of hepatitis C infection: a clinical, histological, and molecular assessment of 35 cases. (2003) (57)
HCV-related cryoglobulinemic vasculitis: an update on its etiopathogenesis and therapeutic strategies. (2003) (57)
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. (2013) (54)
Hepatitis C virus antibodies in mixed cryoglobulinemia. (1991) (54)
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups (2021) (54)
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. (2009) (52)
Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis (1995) (52)
Microvascular involvement in systemic sclerosis: laser Doppler evaluation of reactivity to acetylcholine and sodium nitroprusside by iontophoresis (1998) (51)
CXCL10 in psoriasis. (2015) (50)
Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus. (1993) (50)
Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature. (2013) (50)
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. (2017) (49)
Current treatment of hepatitis C-associated rheumatic diseases (2012) (49)
Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study. (2011) (48)
Scleroderma digital ulcers complicated by infection with fecal pathogens (2012) (46)
Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. (2014) (46)
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (2017) (44)
Heart involvement in systemic sclerosis: an ultrasonic tissue characterisation study (1998) (44)
Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease (1994) (44)
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin (2007) (44)
Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. (2007) (43)
Liver involvement in essential mixed cryoglobulinemia (1979) (42)
Antiendothelial Cell Antibodies Induce Apoptosis of Bone Marrow Endothelial Progenitors in Systemic Sclerosis (2010) (42)
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients (2009) (41)
IP-10 in Autoimmune Thyroiditis (2014) (41)
Assessment of heart involvement. (2003) (41)
Serologic Profile and Mortality Rates of Scleroderma Renal Crisis in Italy (2009) (40)
Hepatitis C virus and mixed cryoglobulinaemia. (1994) (40)
Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters. (2015) (40)
Alpha interferon in the treatment of mixed cryoglobulinaemia patients. (1991) (39)
Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. (1995) (39)
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study. (2015) (39)
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. (2013) (39)
Parvovirus B19 and systemic sclerosis (1999) (37)
Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients: comment on the article by Ray et al. (2002) (36)
New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer (2010) (36)
Plasma-exchange in mixed cryoglobulinemia. Effects on renal, liver and neurologic involvement (1986) (36)
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: the Glucocorticoid Induced OsTeoporosis TOol (GIOTTO) study. (2017) (36)
[Hepatitis C virus infection and arthritis. A clinico-serological investigation of arthritis in patients with or without cryoglobulinemic syndrome]. (2011) (36)
Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infection. (2003) (35)
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. (2005) (35)
Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort. (2013) (35)
Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis. (2012) (35)
Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases. (1997) (35)
Polymoyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection (1996) (34)
The A, B, Cs of viral hepatitis in the biologic era (2010) (34)
Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. (1990) (34)
Osteomyelitis complicating scleroderma digital ulcers (2013) (34)
Systemic sclerosis following human cytomegalovirus infection (2002) (34)
Audiovestibular involvement in systemic sclerosis. (1994) (34)
Hepatitis C virus infection and B-cell lymphomas. (1994) (33)
Non HCV-related mixed cryoglobulinemia. (2007) (33)
Hepatitis C: Thyroid dysfunction in patients with hepatitis C on IFN-α therapy (2009) (31)
Thymus alterations and systemic sclerosis. (2006) (31)
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). (2017) (31)
Chronic hepatitis C and B-cell non-Hodgkin's lymphoma. (1996) (30)
Guidelines for the management of essential mixed cryoglobulinemia. (1995) (30)
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature (2017) (29)
The assessment of anti-endothelial cell antibodies in scleroderma-associated pulmonary fibrosis. A study of indirect immunofluorescent and western blot analysis in 49 patients with scleroderma. (2003) (29)
Serum Concentrations of Interleukin 1ß, CXCL10, and Interferon-γ in Mixed Cryoglobulinemia Associated with Hepatitis C Infection (2010) (29)
Neurologic Complications Associated with Sjögren's Disease: Case Reports and Modern Pathogenic Dilemma (2014) (29)
Role of the HLA Class II (2007) (29)
Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications. (2015) (28)
GISEA: an Italian biological agents registry in rheumatology. (2011) (28)
HCV and cryoglobulinemic vasculitis. (2002) (28)
Cryoglobulins and immune complexes in essential mixed cryoglobulinemia (1986) (28)
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. (2009) (27)
Could HGV infection be implicated in lymphomagenesis? (1997) (27)
Novel Therapies for Thyroid Autoimmune Diseases (2016) (27)
Inhibitory effect of IgM rheumatoid factor on immune complex solubilization capacity and inhibition of immune precipitation. (1984) (27)
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis (2012) (25)
Autologous skin grafting in the treatment of severe scleroderma cutaneous ulcers: a case report. (2003) (25)
Low-antigen-content diet in the treatment of patients with IgA nephropathy (1994) (25)
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes. (2018) (25)
Hepatitis C Virus, B-Cell Disorders, and Non-Hodgkin’s Lymphoma (2000) (25)
Amlodipine in the Treatment of Raynaud's Phenomenon (1993) (25)
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia (2009) (24)
Procedural pain management in the treatment of scleroderma digital ulcers. (2015) (24)
The Assessment of Anti-Endothelial Cell Antibodies in Scleroderma-Associated Pulmonary Fibrosis A Study of Indirect Immunofluorescent and Western Blot Analysis in 49 Patients With Scleroderma (2003) (24)
Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection (2014) (23)
Capillaroscopic Skin Ulcers Risk Index (CSURI) calculated with different videocapillaroscopy devices: how its predictive values change. (2013) (23)
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study (2019) (23)
Lung function in essential mixed cryoglobulinemia: A short-term follow-up (1989) (23)
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register. (2014) (23)
CXCL10 ( a ) and CCL2 ( b ) chemokines in systemic sclerosis—a longitudinal study (2007) (23)
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study (2021) (22)
Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis. (2010) (22)
Immunomodulation of CXCL10 Secretion by Hepatitis C Virus: Could CXCL10 Be a Prognostic Marker of Chronic Hepatitis C? (2019) (22)
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients. (2018) (22)
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study (2021) (22)
Hepatitis C virus in mixed cryoglobulinemia and B cell lymphoma. (1994) (22)
D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature (2011) (22)
Platelet gel in the treatment of severe scleroderma skin ulcers (2012) (21)
Progressive sensorineural hearing impairment in systemic vasculitides. (1998) (21)
Cryoglobulinemic vasculitis and skin ulcers. Our therapeutic strategy and review of the literature. (2015) (21)
Etiopathogenetic role of hepatitis C virus in mixed cryoglobulinemia, chronic liver diseases and lymphomas. (1995) (21)
Oxycodone in the long-term treatment of chronic pain related to scleroderma skin ulcers. (2010) (21)
Aortic pulse wave velocity measurement in systemic sclerosis patients. (2012) (21)
A Paradigmatic Interplay between Human Cytomegalovirus and Host Immune System: Possible Involvement of Viral Antigen-Driven CD8+ T Cell Responses in Systemic Sclerosis (2018) (20)
Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis (2017) (20)
HHV-6A Infection and Systemic Sclerosis: Clues of a Possible Association (2019) (20)
Lung Involvement in Systemic Sclerosis Sine Scleroderma Treated by Plasma Exchange (1992) (20)
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus. (2007) (20)
Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases. (1985) (19)
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia (2017) (19)
Autoimmune-Like Pulmonary Disease in Association With Parvovirus B19: A Clinical, Morphologic, and Molecular Study of 12 Cases (2006) (19)
High levels of circulating N‐terminal pro‐brain natriuretic peptide in patients with hepatitis C (2010) (19)
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis. (2013) (18)
Autoantibodies from mixed cryoglobulinaemia patients bind glomerular antigens (1994) (18)
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up. (2016) (18)
Lymphotropic virus infection of peripheral blood mononuclear cells in B-cell non-Hodgkin's lymphoma. (1997) (18)
Prolonged plasma exchange in the treatment of renal involvement in essential mixed cryoglobulinemia. (1983) (18)
Antibodies against hepatitis C virus in mixed cryoglobulinemia patients (1991) (18)
Recent developments in the therapy of localized and systemic sclerosis. (1994) (18)
Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern (2016) (18)
Ultrasonic videodensitometric analysis in scleroderma heart disease. (1999) (18)
Measuring Microangiopathy Abnormalities in Systemic Sclerosis Patients: The Role of Capillaroscopy-Based Scoring Models (2014) (18)
Correlation of articular involvement, skin disfigurement and unemployment with depressive symptoms in patients with systemic sclerosis: a hospital sample (2014) (17)
Spontaneous chromosome damage (micronuclei) in systemic sclerosis and Raynaud's phenomenon. (2003) (17)
High Serum Levels of CXCL11 in Mixed Cryoglobulinemia Are Associated with Increased Circulating Levels of Interferon-γ (2011) (17)
Treatment patterns of anti-TNF agents in Italy: an observational study. (2011) (17)
Systemic Sclerosis Fibroblasts Show Specific Alterations of Interferon-γ and Tumor Necrosis Factor-α-induced Modulation of Interleukin 6 and Chemokine Ligand 2 (2012) (17)
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases (2021) (17)
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis. (2015) (17)
Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia (2007) (17)
Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia. (1994) (17)
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. (2011) (16)
Renal Manifestations of Hepatitis C Virus. (2017) (16)
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis. (2008) (16)
Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. (1996) (16)
Associations between Systemic Sclerosis and Thyroid Diseases (2017) (16)
Hepatitis C virus infection and type 2 diabetes. (2013) (16)
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis. (2021) (16)
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine. (2014) (16)
Hepatitis‐C virus infection and cabcer (1997) (16)
Inner ear involvement in mixed cryoglobulinaemia patients. (1995) (16)
Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial. (1993) (16)
Skin manifestations in vasculitis and erythema nodosum. (2006) (15)
Thyroid involvement in hepatitis C — Associated mixed cryoglobulinemia (2014) (15)
CXCL10 and CCL2 chemokine serum levels in patients with hepatitis C associated with autoimmune thyroiditis. (2009) (15)
Hepatitis C virus (HCV) in cryoglobulinaemic leukocytoclastic vasculitis (LCV): could the presence of HCV in skin lesions be related to T CD8+ lymphocytes, HLA‐DR and ICAM‐1 expression? (1999) (15)
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 (2013) (15)
Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients (1993) (15)
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. (2013) (15)
Effects of Parvovirus B19 In Vitro Infection on Monocytes from Patients with Systemic Sclerosis: Enhanced Inflammatory Pathways by Caspase-1 Activation and Cytokine Production. (2019) (14)
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series. (2018) (14)
Increased plasma endothelin‐1 immunoreactive levels in vasculitis: a clue to the use of endothelin‐1 as a marker of vascular damage? (1993) (14)
Hepatitis C virus, autoimmune liver disease and cryoglobulinaemic hepatitis. (1992) (14)
Right ventricular overload and cardiovascular neuroendocrine derangement in systemic sclerosis (2004) (14)
Isolated pulmonary hypertension in diffuse cutaneous systemic sclerosis successfully treated with long-term plasma exchange. (2000) (14)
Treatment of HCV-Related Mixed Cryoglobulinemia. (2017) (14)
SAT0621 Validation Study of Predictive Value of Capillaroscopic Skin Ulcer Risk Index (CSURI) in Scleroderma Patients Treated with Bosentan (2015) (13)
Lack of preferential localization of tumoral mass in B-cell non-Hodgkin's lymphoma associated with hepatitis C virus infection. (1997) (13)
[Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)]. (2004) (13)
Amlodipine in the Treatment of Raynaud’s Phenomenon (1997) (13)
[The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results]. (2011) (13)
The safety of iloprost in systemic sclerosis in a real-life experience (2018) (12)
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature (2017) (12)
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity. (2014) (12)
N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha both are increased in patients with Hepatitis C. (2010) (12)
Parvovirus B 19 infection of bone marrow in systemic sclerosis patients (2006) (12)
Plasma exchange in the treatment of progressive systemic sclerosis (1987) (12)
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines (2012) (11)
Immune complex behaviour during prolonged plasma exchange in essential mixed cryoglobulinemia and systemic lupus erythematosus. (1985) (11)
Severe urinary bladder involvement in systemic sclerosis. Case report and review of the literature. (1998) (11)
Scintigraphic findings on99mTc-MDP,99mTc-sestamibi and99mTc-HMPAO images in Gaucher's disease (1996) (11)
Lung function abnormalities in different connective tissue diseases (1986) (11)
Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations. (2017) (11)
Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic (2020) (11)
HCV-Related Rheumatic Manifestations and Therapeutic Strategies. (2017) (11)
Endocrine disorders associated with hepatitis C virus chronic infection (2018) (11)
Antinuclear Antibody Profile in Italian Patients with Connective Tissue Diseases (1992) (11)
Hepatitis C virus and lymphoproliferative disorders. (1996) (11)
[CXCR3 and CXCL10 in autoimmune thyroiditis]. (2014) (11)
Cardiovascular risk and prostanoids in systemic sclerosis. (2008) (11)
Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study. (2017) (11)
Paraneoplastic rheumatic disorders: a narrative review. (2018) (10)
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. (2021) (10)
[Dactilitis and oligoarthritis after BCG immunotherapy in a patient affected by bladder cancer]. (2011) (10)
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. (2013) (10)
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis (2019) (10)
Mixed cryoglobulinemia and thyroid autoimmune disorders. (2013) (10)
Impact of Human Cytomegalovirus and Human Herpesvirus 6 Infection on the Expression of Factors Associated with Cell Fibrosis and Apoptosis: Clues for Implication in Systemic Sclerosis Development (2020) (10)
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers (2010) (10)
Changes in T-cell responses against human herpesvirus-8 correlate with the disease course of iatrogenic Kaposi's sarcoma in a patient with undifferentiated arthritis. (2009) (10)
Plasma exchange in the treatment of lupus nephritis. (1983) (10)
Quantitative evaluation of 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases. (1978) (10)
High circulating levels of N‐terminal pro‐brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia (2010) (10)
Chromosome aberrations in Raynaud's phenomenon. (2004) (9)
Treatment strategies for a patient with rheumatoid arthritis and hepatitis C (2009) (9)
Peroxisome proliferator‐activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts (2013) (9)
[Extrahepatic manifestations of hepatitis C virus: the thyroid disorders]. (2005) (9)
Hepatitis C virus and mixed cryoglobulinaemia. (1993) (9)
Epstein-Barr Virus Reactivation after Infliximab in Rheumatoid Arthritis: A Case Report (2011) (9)
High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia (2013) (9)
Long-term griseofulvin treatment for progressive systemic sclerosis. (1986) (9)
Systemic sclerosis chronic ulcers: preliminary results of treatment with allogenic skin grafting in a cohort of Italian patients (2016) (8)
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy (2014) (8)
OP0275 Nailfold Videocapillaroscopy and Other Predictive Factors Associated with New Digital Ulcers in Systemic Sclerosis: Data from the Cap Study (2013) (8)
Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders. (1998) (8)
Gruppo Italiano di Studio sulle Early Arthritides (GISEA). Longtermretention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal ofpredictors. (2012) (8)
Treatment strategies for a patient with rheumatoid arthritis and hepatitis C. (2009) (8)
The Emerging Extrahepatic Manifestations of Hepatitis C Virus Infection in Chronic Hepatitis and Mixed Cryoglobulinemia (2008) (8)
Successful treatment with leflunomide of arthritis in systemic sclerosis patients. (2006) (8)
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinaemia are associated with circulating levels of IFN-gamma and TNF-alpha. (2012) (8)
High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10. (2012) (8)
Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease. (1996) (8)
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases (2022) (8)
Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features. (2014) (8)
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls (2011) (8)
[The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients]. (2011) (8)
Metformin and Heart Failure: Innocent Until Proven Guilty (2006) (8)
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients. (2017) (8)
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study (2019) (8)
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum. (2020) (8)
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report (2018) (8)
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2 (2021) (8)
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases (2020) (7)
Hepatitis E virus and systemic sclerosis. (1998) (7)
Bone involvement in Gaucher's disease: 'bone crisis' or disease complication? (1996) (7)
Nailfold capillary microscopy in lacunar infarction. (1994) (7)
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease. (2016) (7)
Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis (2020) (7)
Golimumab: A Novel Anti-Tumor Necrosis Factor (2013) (7)
Human Parvovirus B 19 ( B 19 V ) Infection in Systemic Sclerosis Patients (2009) (7)
Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection. (2005) (7)
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation (2018) (7)
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology (2021) (7)
Slow-releasing nicardipine in the treatment of Raynaud's phenomena without underlying diseases (1992) (7)
Staphylococcus Protein A‐based Extracorporeal Immunoadsorption and Thalidomide in the Treatment of Skin Manifestation of Dermatomyositis: A Case Report (2009) (6)
Hepatocellular carcinoma in mixed cryoglobulinemia patients. (1996) (6)
Hepatitis C Virus Infection: Evidence for an Association With Type 2 Diabetes: Response to Skowroński et al. (2006) (6)
Type C hepatitis and chronic lymphocytic leukaemia. (1996) (6)
Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases (2021) (6)
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. (2014) (6)
Cryoglobulinaemic vasculitis as presenting manifestation of infective endocarditis (2002) (6)
Expert Opinion on Managing Chronic HCV in Patients with Non-Hodgkin Lymphoma and other Extrahepatic Malignancies (2018) (6)
Effects of Rituximab in a large series of patients with HCV-associated mixed cryoglobulinemia syndrome (2010) (5)
Lymphocyte subpopulation in essential mixed cryoglobulinemia. (1986) (5)
Hypotensive effect of plasma exchange in immune complex nephritis. (1985) (5)
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines. (2014) (5)
Induction of CXCL10 secretion by interferon‐γ and tumour necrosis factor‐α and its inhibition by peroxisome proliferator‐activated receptor‐γ agonists in cultured scleroderma fibroblasts (2010) (5)
OP0228 Rituximab Monotherapy of Severe Hcv-Related Cryoglobulinemic Vasculitis for More than 2 Years: Follow-Up of A Randomized Controlled Multicentre Study (2014) (5)
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection (2013) (5)
L-Arginine in pregnant scleroderma patients (2010) (5)
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia. (2017) (5)
Immunomodulation of CXCL 10 Secretion by Hepatitis C Virus : Could CXCL 10 Be a Prognostic Marker of Chronic Hepatitis C ? (2019) (4)
COVID-19 vaccine hesitancy in systemic sclerosis. (2021) (4)
From internal medicine to rheumatology and back: the example of mixed cryoglobulinemia. (1995) (4)
Plasma levels of endothelin-1 in mixed cryoglobulinaemia patients. (1994) (4)
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases (2022) (4)
Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life. (2021) (4)
IgA nephropathy: preliminary results of low-antigen-content diet treatment. (1992) (4)
[Correlation of a quantitative videocapillaroscopic score with the development of digital skin ulcers in scleroderma patients]. (2011) (4)
Hepatitis-C-virus infection and cancer. (1997) (4)
Elevated Troponin Serum Levels in Adult Onset Still's Disease (2015) (4)
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience. (2017) (4)
Hepatitis C virus and type 1 diabetes. (2013) (4)
From Essential Mixed Cryoglobulinemia to Virus-induced Autoimmunity: Ten Years of Research on Mixed Cryoglobulinemia (1999) (4)
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis (2010) (4)
17 - HCV and Cryoglobulinemia (2004) (4)
Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon. (1996) (4)
Hepatitis C virus infection and cutaneous vasculitis in mixed cryoglobulinemia. (1996) (4)
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline. (2016) (4)
[A review on thyroid autoimmune disorders and HCV chronic infection]. (2014) (4)
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature (2013) (3)
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease]. (2014) (3)
Role of CXCL10 in cryoglobulinemia. (2015) (3)
AISF position paper on HCV in immunocompromised patients (2019) (3)
Hepatitis C is Associated with High Levels of Circulating N-Terminal Pro-Brain Natriuretic Peptide and Interleukin-6 (2012) (3)
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal (2018) (3)
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia. (2009) (3)
Scintigraphic findings on 99 rnTc-MDP , 99 rnTc-sestamibi and 99 mTc-HMPAO images in Gaucher ' s disease (3)
COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies (2022) (3)
Type C chronic hepatitis complicated by B-cell lymphoma. (1995) (3)
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group (2021) (3)
The Expanding Spectrum of Clinical Features in HCV-Related Mixed Cryoglobulinemia. (2012) (3)
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy (2021) (3)
Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies. (2022) (3)
FRI0234 Complement depletion in rheumatoid arthritis patients treated with tocilizumab: a marker of clinical efficacy? (2013) (3)
[The alpha chemokine "Interferon gamma-induced protein 10" (IP-10) in Graves' disease and Graves'ophthalmopathy]. (2014) (3)
Phantom Limb Pain in Patients with Severe Cryoglobulinemic Vasculitis: Usefulness of Long-Term Pregabalin Treatment (2012) (3)
Our therapeutic strategy and review of the literature (2014) (2)
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. (2022) (2)
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis. (2022) (2)
Viral infections and systemic sclerosis. (2014) (2)
AB0615 Persistence of human papillomavirus in the cervix of women with systemic sclerosis (2017) (2)
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series (2022) (2)
Extra-Hepatic Manifestations of Hepatitis C Virus Infection (2018) (2)
Isolated “puffy hands” following COVID-19: clue to a long-term capillary leakage syndrome? (2021) (2)
Acute effect of plasma exchange on arterial blood pressure and plasma renin activity. (1985) (2)
AB0616 Cost analysis related to subcutaneous immunoglobulins in patients with inflammatory myopathies and immune-mediated chronic neuropathies. results of an open label study (2017) (2)
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature (2015) (2)
Parvovirus B19 and systemic sclerosis. (2005) (2)
Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or Spondyloarthritides (2014) (1)
POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY (2021) (1)
The pathogenesis of the anaemia of chronic disorders. (2012) (1)
Heart Involvment in Systemic Sclerosis: an Ultrasonic Tissue Characterization Study. 1st International Congress on Heart Disease – New Trends in Research, Diagnosis and Treatment. Washington DC, USA, May 16-19, 1999. (1999) (1)
Basic (PS01–PS58) (2012) (1)
An Italian multicenter controlled study of HCV-related malignancies: Role of the HLA class II (2006) (1)
BCL-2 rearrangement in mixed cryoglobulinemia and HCV-positive liver disease patients (1998) (1)
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes]. (2011) (1)
Lymphoma Prevalence in Patients with Serum Cryoglobulins with or without Cryoglobulinemic Vasculitis: Data Extrapolated From the Cryoglobulinemic Vasculitis Classification Criteria Database. (2011) (1)
Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study. (2017) (1)
SAT0298 Nailfold Capillaroscopic Alterations in Dermatomyositis and Polymyositis (2014) (1)
Chronic inflammation, including autoimmunity, and lymphomagenesis (2010) (1)
11. Recent Advances in Therapy (2018) (1)
Low antigen content diet in the management of immunomediated diseases. (1992) (1)
Proinflammatory cytokines (IL-1b, IL-6 and TNF-alpha) serum levels in mixed cryoglobulinemia (2009) (1)
AB0465 Etanercept therapy in rheumatoid arthritis patients with moderate or severe disease activity (2013) (1)
AB0416 Early Good Eular Response Predicts Low/Remission Disease State in Rheumatoid Arthritis Patients on Treatment with Certolizumab in Real Life Settings. Data from Italian Registry Gisea (2015) (1)
Antidepressants for the treatment of fibromyalgia. (2009) (1)
Role of CXCL 10 in cryoglobulinaemia (2015) (1)
The blood pressure lowering effects of plasma exchange. (1985) (1)
[Diffuse post-traumatic calcification of the anterior longitudinal ligamentum of cervical and dorsal spine]. (2011) (1)
FRI0451 Unclassifiable Interstitial Lung Disease or Undifferentiated Connective Tissue Disease? A Challenging Differential Diagnosis (2015) (1)
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING (2019) (1)
PMS62 DISCONTINUATION RATE OF THE IST AND IIND ANTI-TUMOR NECROSIS FACTORTHERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY (2008) (1)
[Cryoglobulinemia and the α-chemokine IP-10]. (2014) (1)
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (2017) (1)
OP0274 Cryoglobulinemic Vasculitis and Primary sjögren's Syndrome are Independent Risk Factors for Lymphoma in a Large Worldwide Population of Patients with Positive Serum Cryoglobulins (2015) (1)
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) (2022) (1)
Non HCV-related mixed cryoglobulinemia Ngcstive and Liver Disease (2007) (1)
THU0395 Adult Onset Still's Disease: A Multicenter Retrospective Cohort Study of 233 Italian Patients (2014) (0)
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. (2015) (0)
Micro and Nanoparticles As Possible Causative-Prognostic Co-FactorsOf Mixed Cryoglobulinemia Syndrome (2013) (0)
mixed cryoglobulinemia Infection of peripheral blood mononuclear cells by hepatitis C virus in (2011) (0)
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy (2015) (0)
Long term and short term effects of plasma exchange on arterial blood pressure (1994) (0)
Autoimmunity in porphyria cutanea tarda associated with HCV infection (1993) (0)
Factors Influencing Choice of Rituximab Versus an Alternative Tumor Necrosis Factor Inhibitor Following Tumor Necrosis Factor Inhibitor Failure in Patients with Rheumatoid Arthritis: Sub-Analysis of a Global, Observational Comparative Effectiveness Study (2012) (0)
Mixed cryoglobulinemia: the role of HCV and organ-specific antibodies (1996) (0)
Is T(14;18)(q32;q21) translocation a hallmark of HCV-related mixed cryoglobulinemia? (2000) (0)
[Minor connectivitis and the mixed connective tissue disease]. (1980) (0)
PERIPHERAL ARTERIAL CHANGES IN SYSTEMIC SCLEROSIS PATIENTS ARE SIMILAR TO THOSE OBSERVED IN PATIENTS WITH CORONARY ARTERY DISEASE (2011) (0)
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients (2015) (0)
Cryoglobulinemia Associated with Hepatitis C Infection in Mixed γ Serum Concentrations of Interleukin 1 ß , CXCL 10 , and Interferon - (2009) (0)
KIENBOCK DISEASE IN A PATIENT WITH SSc: A CASE REPORT (2012) (0)
Microcirculatory dysfunction and sympathetic hyperthonus in systemic sclerosis: a study by skin laser doppler and RR interval power spectrum analysis (1997) (0)
Letters to the Editor Nallfold Capillary Microscopy in Lacunar Infarction (0)
Covid-19 Epidemiology, Pathogenesis and Therapy. (2021) (0)
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry ‘SPRING’ of the Italian Society for Rheumatology (2023) (0)
Depression in rehumatic patients (2009) (0)
Changes in blood pressure and plasma renin activity induced by plasma exchange in hypertensive nephritis (1993) (0)
Interstitial lung fibrosis in patients with hepatitis C virus infection (1998) (0)
Subject Index, Vol. 43, 1986 (1986) (0)
CAPILLAROSCOPIC SKIN ULCER RISK INDEX (CSURI) IN SYSTEMIC SCLEROSIS: RESULTS FROM AN ITALIAN MULTICENTER VALIDATION STUDY (2011) (0)
Audio-vestibular involvement in Systemic Sclerosis (1994) (0)
RECRUITMENT OF CD271(+) MESENCHYMAL STEM CELLS FROM BONE MARROW TO SKIN IN ACTIVE SSc: A ROLE IN FIBROSIS DEVELOPMENT (2012) (0)
BCG and Autoimmunity (2015) (0)
[Chromosome aberrations, valued as frequency of spontaneous micronuclei, in subjects with suspected presclerodermic Raynaud's phenomenon]. (2011) (0)
Severe alopecia complicating systemic sclerosis. (2015) (0)
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY (2009) (0)
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience (2018) (0)
The pathogenesis of anemia of chronic disorders (2012) (0)
Improvement of endothelial function and its relationship with exercise capacity and hemodynamic profile in patients with pulmonary hypertension. A randomized study comparing bosentan and sildenafil (2008) (0)
Erratum to: Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature (2013) (0)
Lung and Breast Cancer in Systemic Sclerosis: Correlations with the Disease's Features (2011) (0)
AB0629 From localized scleroderma to systemic sclerosis: a possible evolution (2017) (0)
IX Eular Workshop for Rheumatology Research (1989) (0)
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT (2014) (0)
Extrahepatic Manifestations of Hepatitis C Virus Infection (1996) (0)
Evidence of HCV genome in cutaneous vasculitis from mixed cryoglobulinaemia patients: correlation with immunopathologycal studies (1998) (0)
Cardiac Involvement in Systemic Vasculitis (2017) (0)
Serum α-Chemokine CXCL10 and β-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia (2012) (0)
Kienböck Disease in a patient with systemic sclerosis: a case report. (2012) (0)
S.1.1 Organ function and quality of life correlates at randomization on the SCOT (Scleroderma: Cyclophosphamide Or Transplantion) Trial (2012) (0)
ALLOGENIC SKIN GRAFTING FOR SYSTEMIC SCLEROSIS ULCERS: PRELIMINARY DATA OF AN ITALIAN COHORT (2014) (0)
Transient serum anti-Scl70 antibodies and interstitial lung involvement in acute EBV infection (2008) (0)
Lymphoma Associated With Hepatitis C Virus Infection Lack of Preferential Localization of Tumoral Mass in B-Cell Non-Hodgkin's (2011) (0)
Eosinophilic globules in bronchoalveolar lavage fluid of patients with systemic sclerosis-related interstitial lung disease: a diagnostically useful, previously unreported finding in a retrospective and prospective study, including differential diagnosis with other idiopathic and secondary interstit (2008) (0)
AB0637 Iloprost (ILO) in Systemic Sclerosis (SSC): The Safety Experience of Two Italian Centres (2016) (0)
Comorbid depression in rheumatic patients (2008) (0)
FRI0388 Long-term treatment with rituximab in systemic sclerosis patients: update of our clinical experience (2017) (0)
[Percutaneous vertebroplasty as therapy for vertebral fractures: results in a series of osteoporotic patients]. (2011) (0)
[HCV-associated cryoglobulinemic vasculitis]. (2012) (0)
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal (2018) (0)
AB0716 Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline (2015) (0)
Cryoglobulinaemia and Hepatitis C Virus 42 Learning (2012) (0)
Thyroid involvement in HCV-related cryoglobulinemic vasculitis (2005) (0)
Microcirculatory involvement in Raynaud 's phenomenon and systemic sclerosis (1995) (0)
Might hypnotic drug formulation impact on the potential for abuse (2017) (0)
Hepatitis C virus syndrome : A constellation (2015) (0)
A proposal of screening for psychiatric disorders in a rheumatologic ward. (2009) (0)
Acknowledgement to Referees (2013) (0)
Parvovirus B19 as possible triggering factor of endothelial and fibroblast alterations in systemic sclerosis (2004) (0)
SAT0633-HPR Articular Involvement of the Scleroderma Hand: An Assessment Protocol for Planning Occupational Therapy Strategies (2015) (0)
Chapter 52 - Cryoglobulins and Cryoglobulins Secondary to Hepatitis C Virus Infection (2014) (0)
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME (2019) (0)
AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study (2013) (0)
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS (2014) (0)
AB0342 Rheumatoid Arthritis Related Interstitial Lung Disease. Radiological Patterns and Correlations with Clinical, Serological and Demographic Features of Disease (2014) (0)
Hepatitis C Virus Lymphotropism and Possible Pathogenetic Implications. (1996) (0)
ANTICOLLAGEN ANTIBODIES IN CONNECTIVE-TISSUE DISORDERS (1992) (0)
If confirmed in a larger series of patients with MC, these findings could definitively clarify the pathogenetic role of HCY in cryoglobulinemic vasculitis. (1996) (0)
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity (2023) (0)
Predictors, Features and Effects of First Biologic Switch in Rheumatoid Arthritis within GISEA register: Italian 10-Year Experience (2011) (0)
Correction to: Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) (2022) (0)
PMS36 COST OF THERAPY OF TUMOR NECROSIS FACTOR BLOCKING AGENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ITALY (2008) (0)
Chronic inflammation, including autoimmunity, and lymphomagenesis : SA PILERI, C AGOSTINELLI, C CAMPIDELLI, F BACCI, E SABATTINI, M GIUNTI, A PILERI, M PICCIOLI, S RIGHI, M ROSSI, C FERRI AND PP PICCALUGA (2010) (0)
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung (2014) (0)
Validation Study Of The International Classification Criteria For TheCryoglobulinemic Vasculitis (2013) (0)
SAT0029 Mesenchymal stem cells modulate in vitro fibroblast activity in systemic sclerosis (2013) (0)
Arterial stiffness evaluation in patients with systemic sclerosis: an interesting correlation with right ventricular function and cardiopulmonary performance (2009) (0)
Thyroid cancer in patients with chronic hepatitis C virus infection (2000) (0)
Endocrine Manifestations of HCV-Positive Cryoglobulinemia (2012) (0)
Vasculiti ANCA associate (2013) (0)
Mixed cryoglobulinaemia and hepatitis C virus: a paradigm of a virus-related autoimmune and lymphoproliferative disorder. (2021) (0)
Patients with Mixed Cryoglobulinemia and HCV Infection, in Presence or Absence of Autoimmune Thyroiditis, Have High Serum Levels of (CXC MOTIF) Ligand (CXCL)9 and CXCL11 Chemokines (2012) (0)
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland (2008) (0)
Extrahepatic Manifestations of Chronic HCV Infection. (2021) (0)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES (2009) (0)
Prevention of Digital Ulcers in Systemic Sclerosis Patients: A Proposal of Risk Chart. (2011) (0)
Cryoglobulinaemia and hepatitis C virus (2012) (0)
AB0688 Treatment with Rituximab in Systemic Sclerosis Patients: Our Experience in a Pilot Clinical Trial (2015) (0)
AB0381 Long-Term Clinical Effectiveness of Adalimumab, Etanercept, and Infliximab in Rheumatoid Arthritis (RA): an Observational Study from Italian Register, Gisea (2014) (0)
Mixed cryoglobulinemia syndrome: where are we going to? (2009) (0)
SAT0175 Results of the Classification Criteria for Cryoglobulinemic Vasculitis Validation Study (2013) (0)
Papillary cystadenocarcinoma of a broad ligament cyst. (1955) (0)
AB0623 Treatment of Scleroderma-Related Digital Ulcers with Iloprost: A Cohort Study (2016) (0)
Effects of alpha-interferon on cryobulinemic hepatitis (1993) (0)
THU0246 Psychiatric disorders in rheumatology: Evaluation of a screening protocol in 100 hospitalized patients (2013) (0)
Alta frequenza di micronuclei spontanei osservati in linfociti di pazienti con sclerosi sistemica: risultati preliminari* The high frequency of spontaneous micronuclei observed in lymphocytes of systemic sclerosis patients: preliminary results (2002) (0)
Photoperesis and systemic sclerosis (1992) (0)
Neurological toxicity of alpha-interferon in HCV- or HBV-related immunological systemic disorders (1998) (0)
[Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs]. (2009) (0)

This paper list is powered by the following services:

Other Resources About Clodoveo Ferri

en.wikipedia.org

What Schools Are Affiliated With Clodoveo Ferri?

Clodoveo Ferri is affiliated with the following schools: